Showing results (1531-1540 of 1,580) with videos related to

Sort By:
Pageof 158
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 15, 2022
Impact of integrating genomic data into the electronic health record on genetics care deliveryKelsey S Lau-Min, Danielle McKenna, Stephanie Byers Asher, et al.
Journal of Medicinal Chemistry|January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitorsBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2021
EUS-based Pancreatic Cancer Surveillance in <i>BRCA1/BRCA2/PALB2/ATM</i> Carriers Without a Family History of Pancreatic CancerBryson W Katona, Jessica M Long, Nuzhat A Ahmad, et al.
Cell|July 7, 2010
Discovery of a proneurogenic, neuroprotective chemicalAndrew A Pieper, Shanhai Xie, Emanuela Capota, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|December 13, 2016
[Prevalence of hearing disorders in China: a population-based survey in four provinces of China]X Y Hu, X Y Zheng, F R Ma, et al.
Lancet (London, England)|June 5, 2003
Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infectionYi Jun Ruan, Chia Lin Wei, Ai Ling Ee, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 27, 2023
Screening for quality with process analytical technology in a health-system pharmacy: A primerPhilip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Oncotarget|March 18, 2011
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human healthWilliam H Chappell, Linda S Steelman, Jacquelyn M Long, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinaseVictor J Cee, Alan C Cheng, Karina Romero, et al.
Pageof 158